Asset Entities ASST Medical Device — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Asset Entities's medical device — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Asset Entities's medical device — D&A?
- Asset Entities (ASST) reported medical device — D&A of $32K in Q1 2026.
- What does medical device — D&A mean?
- This represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the business segment. It reflects the wear and tear or expiration of assets used to generate segment revenue. This metric is vital for understanding the capital intensity and reinvestment requirements of the business unit.